INTRODUCTION
F-FET uptake is primarily mediated by the system L amino acid transporter subtypes LAT1 and LAT2 (3, 4) . These transporters are heterodimers consisting of a light (LAT1, LAT2) and a heavy chain (CD98) and function as obligatory stereospecific exchanger (antiporter) of neutral amino acids (3, 4) . LAT1/LAT2 are highly expressed in primary brain tumors. The highest levels have been detected in glioma cells and tumor-associated endothelium (5) . Consequently, 18 F-FET PET has a high specificity for gliomas mediated by a tracer uptake almost independent of blood-brain barrier (BBB) dysfunction.
18
F-FET uptake by non-neoplastic tissue is considered as a rare phenomenon and has been reported for various inflammatory and vascular brain lesions (1, (6) (7) (8) (9) (10) .
Epileptic seizures are among the most common symptoms of primary brain tumors (11) .
Focal symptoms after seizures usually disappear within 36 hours (12) (13) (14) . Prolonged postictal deficits, however, are often similar to symptoms that arise from progressive tumor growth. On the other hand, an increase of seizure frequency may be an early sign of tumor progression (11, 15) . Therefore, the differentiation of purely seizure-related postictal symptoms from tumor progression is of paramount importance in the clinical management of brain tumor patients.
To complicate this matter, seizure activity, in particular status epilepticus, may result in MRI changes difficult to differentiate from tumor progression (16). For 
MATERIALS AND METHODS

Study design and data collection
We identified eight patients with gliomas WHO grade II-IV and two patients with nonneoplastic diseases from three neurooncology centers (Salzburg, Austria; Regensburg and The local ethics committee of the University of Regensburg approved this retrospective study (number 14-101-0185) and the requirement to obtain informed consent was waived. The study was conducted according to the standards of the Declaration of Helsinki in its recent revised version of 2013.
Standard MR imaging
Standard MR imaging was routinely performed at the local departments of neuroradiology.
At the time of seizure disorder and afterwards in the course of disease, all patients received MRI scans using 1.5 T or 3.0 T scanners with standard head coils before and after administration of a gadolinium-based contrast agent. The routine MRI protocol included T1-weighted sequences with and without contrast agent (T1w, T1wCE), T2 and FLAIR sequences, and MR diffusionweighted imaging (DWI) with calculation of the apparent diffusion coefficient (ADC). In five patients, additional dynamic susceptibility contrast (DSC) PWI was available.
MR image analysis
For study evaluation, the cortical changes in standard MRI and, if available, DSC-PWI were retrospectively reviewed by two independent investigators (C.W., M.H.). During this analysis, contrast enhancement in T1wCE sequence (BBB permeability), T2/FLAIR sequences (hyperintensity, vascular edema), DWI/ADC sequences (diffusion restriction, cytotoxic edema) and DSC-PWI (hypo-or hyperperfusion) were graded visually on a three-point scale (no, weak and strong).
F-FET PET imaging
18 F-FET PET was routinely performed at the local departments of nuclear medicine according to the German and Austrian guidelines for brain tumor imaging using labeled amino acid analogues (21). All patients fasted for at least 6 hours before PET scanning. Prior to the investigation, a low-dose computer tomography (CT) scan was performed for attenuation correction. PET acquisition was started 20 minutes after intravenous injection of about 250 MBq F-FET uptake was expressed as standardized uptake values (SUV). The ROI of the suspicious lesion was determined using a three-dimensional autocontouring process with a lesion-to-brain ratio (LBR) of ≥1.6 as described previously (22).
Because of the reversibility of seizure-related cortical tracer uptake in follow-up studies and 18 F-FET PET shortly before seizure activity cortical LBRmax was <1.6. In these cases a circular ROI with a diameter of 1.6 cm was centered exactly on the cortex of maximal (extension ≤5 cm), "enlarged" (extension >5 cm, within one lobe), and "widespread" (more than one lobe).
In one patient (case 3), a time-activity curve of SUVmean in the frontal epileptic brain lesion was generated by measuring a spherical volume-of-interest of 2 ml centered on the maximal 18 F-FET brain lesion uptake and in a reference ROI of unaffected brain (as described above) using the entire dynamic dataset.
Histological assessment and immunostaining
Histological specimen were available for study analysis from two patients of the study cohort ( Table 2) 
RESULTS
Study population
In this multicenter study, ten patients with eleven episodes of SES/SE were identified (eight patients with gliomas WHO grade II-IV; two patients with non-neoplastic diseases and final diagnoses of ischemic stroke and non-convulsive SE caused by septic encephalopathy; Table 1 ). One patient presented with identical serial focal motor seizures and focal SE followed by prolonged postictal hemiparesis in 2011 and 2014. Because combined MRI and 18 F-FET PET was available from both time points, this patient was examined twice (case 1 and 2).
18
F-FET PET was performed during or within 7 days after termination of the clinical and/or EEG signs of seizure activity (Table 2 ). MRI and 18F-FET PET were also obtained out of an epileptic episode. This was during the clinical follow-up after seizure initiation in 5 cases (range, +8 to +12 weeks) and before seizure onset in 2 other cases (-4 and -10 weeks).
Structural MRI changes during seizure activity
During SES/SE and prolonged postictal symptoms we observed structural MRI changes including cortical hyperintensity in T2/FLAIR sequences and diffusion-restriction with low ADC values in DWI/ADC (9/11 cases; Table 2 ; Figs In case 3, the time-activity curve of 18 F-FET uptake in the frontal epileptic brain lesion was calculated and compared to the unaffected contralateral hemisphere (Fig. 2D) . The curve pattern showed a continuously increasing 18 F-FET uptake without clear identifiable peak uptake and wash-out kinetics, comparable to that usually observed in low-grade gliomas.
F-FET uptake and prolonged postictal symptoms
Four SES/SE patients showed an increased and widespread cortical 18 F-FET uptake spreading into two or three lobes, combined with cortical vasogenic and cytotoxic edema and partial contrast enhancement in MRI (cases 1, 2, 5, 6). This observation was associated with prolonged postictal symptoms lasting 1 to 6 weeks ( Table 2 ).
In contrast, case 4 suffered from clinical stable anaplastic astrocytoma WHO grade III without residual tumor over years and presented with a TCS followed by severe postictal symptoms over 8 weeks (Fig. 3) . This condition was associated with distinctly increased cortical 
Histopathological evaluation and immunostaining
Since the results of MRI and (Figs. 4C-F) .
In seizure-affected cortex, LAT1/LAT2/CD98 amino acid transporter showed a strong and extended expression in neurons and brain endothelium (Figs. 4A-B) , and was also detected in reactive astrocytes, especially when located adjacent to brain capillaries (Fig. 4B) Table 1) , quantification of tracer uptake should in principle lead to similar results. In any case, it can be assumed that the methodological differences are less relevant for intra-individual courses.
Structural changes of the brain cortex in MRI are the most stereotypic imaging features suggesting seizure activity or status epilepticus (16). On this account, the combination of a strict gyral, and mostly extended, Interestingly, also neurons in the infiltration zone of glial tumors strongly expressed LAT1/LAT2/CD98, in particular when directly interacting with tumor cells as "satellites" (Fig.   4C ). This observation supports the hypothesis of a link between LAT1/LAT2/CD98 expression and epileptogenesis, since in glial brain tumors epileptogenic activity arises in the cortex adjacent to the tumor, while the tumor itself is considered electrically inert with regard to seizure initiation (25). Structural and metabolic changes in the peritumoral tissue may lead to cortical cell alterations with imbalance between excitatory and inhibitory neurotransmitter, especially high intra-and peritumoral glutamate levels (25-27).
Reactive astrocytosis has been shown to be associated with increased 18 F-FET uptake in various non-neoplastic brain lesions (e.g., inflammatory and demyelinating lesions, brain ischemia and hemorrhage, brain abscesses and radiation necrosis), representing another potential "pitfalls" in 18 F-FET PET (1, (6) (7) (8) (9) (10) . In the presented group of patients, however, there were no clinical or radiological signs that would have been consistent with one of these differential diagnoses. Furthermore, the presented lesions showed a strict gyral pattern, which is untypical for the lesions mentioned above and suggests a connection with an epileptogenic genesis. This notion is further supported by the fact that in specimen of seizure-affected cortex LAT1/LAT2/CD98 was stronger expressed in neurons and brain endothelium than in reactive astrocytes, indicating a predominant neuronal 18 F-FET uptake during seizure activity.
Other aspects that need to be discussed concerns the relationship of seizure-mediated increased 18 F-FET uptake, regional blood flow and blood-brain-barrier disruption. Numerous PET and SPECT studies using various tracers have shown that the cerebral blood flow is increased in the ictal and decreased in the interictal state (28) . In the present report, enhanced cortical 18 F-FET uptake was observed in brain areas with increased (Figs. 1-3 ) and decreased regional perfusion as well as increased (Supplemental Fig. 1) and decreased (Fig. 3) glucose metabolism. Similarly, previous studies have shown high 18 F-FET uptake in gliomas with low cerebral blood flow or blood volume (29, 30) . Therefore, it is unlikely that increased Enhanced amino acid uptake during seizure activity has also been discussed in a few case reports using 11 C-methionine ( 11 C-MET) (33) (34) (35) , which is also transported via LAT1/LAT2 (36) . Moreover, increased amino acid uptake in epileptic foci was reported for PET using α- (37, 38) , which measures the serotonin synthesis rate. It was speculated that its increased uptake in epileptogenic tubers reflects changes in the kynurenine pathway. Since L-tryptophan is also a substrate of LAT1/LAT2 (39), it is tempting to hypothesis that increased 11 C-AMT uptake in epileptogenic foci has also been influenced by increased LAT1/LAT2 transport as observed in the present study for 
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